151 related articles for article (PubMed ID: 36346024)
1. Cutaneous lupus erythematosus variants responsive to Janus kinase inhibition.
Ananthan L; Williams M; Morgan H; Patel GK
Dermatol Ther; 2022 Dec; 35(12):e15967. PubMed ID: 36346024
[No Abstract] [Full Text] [Related]
2. Management of cutaneous lupus erythematosus with Janus kinase inhibitor therapy: An evidence-based review.
Abduelmula A; Sood S; Mufti A; Hinek A; Yeung J
J Am Acad Dermatol; 2023 Jul; 89(1):130-131. PubMed ID: 36935014
[No Abstract] [Full Text] [Related]
3. Assessment of Clinical Response to Janus Kinase Inhibition in Patients With Familial Chilblain Lupus and TREX1 Mutation.
Zimmermann N; Wolf C; Schwenke R; Lüth A; Schmidt F; Engel K; Lee-Kirsch MA; Günther C
JAMA Dermatol; 2019 Mar; 155(3):342-346. PubMed ID: 30673078
[TBL] [Abstract][Full Text] [Related]
4. Subacute cutaneous lupus erythematosus presenting in twins.
Montuno MA; Church AA; Schoch JJ; Andrews ID
Pediatr Dermatol; 2018 Mar; 35(2):e128-e131. PubMed ID: 29436018
[TBL] [Abstract][Full Text] [Related]
5. Ruxolitinib Attenuates Cutaneous Lupus Development in a Mouse Lupus Model.
Chan ES; Herlitz LC; Jabbari A
J Invest Dermatol; 2015 Jul; 135(7):1912-1915. PubMed ID: 25789705
[No Abstract] [Full Text] [Related]
6. Chilblain lupus erythematosus.
Patel S; Hardo F
BMJ Case Rep; 2013 Nov; 2013():. PubMed ID: 24285807
[TBL] [Abstract][Full Text] [Related]
7. Selective Janus Kinase 1 Inhibition Is a Promising Therapeutic Approach for Lupus Erythematosus Skin Lesions.
Fetter T; Smith P; Guel T; Braegelmann C; Bieber T; Wenzel J
Front Immunol; 2020; 11():344. PubMed ID: 32194562
[TBL] [Abstract][Full Text] [Related]
8. Update on the management of cutaneous lupus erythematosus.
Callen JP
Br J Dermatol; 2004 Oct; 151(4):731-6. PubMed ID: 15491411
[TBL] [Abstract][Full Text] [Related]
9. [Cutaneous lupus erythematosus and skin manifestations in systemic lupus erythematosus].
Sticherling M
Z Rheumatol; 2013 Jun; 72(5):429-35. PubMed ID: 23743985
[TBL] [Abstract][Full Text] [Related]
10. [Chronic lupus erythematosus, subacute cutaneous lupus].
Doutre MS; Beylot C
Rev Prat; 1990 Sep; 40(21):1930-4. PubMed ID: 2237183
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous lupus erythematosus limited to the site of a laceration.
Timani S; Mutasim DF
J Cutan Med Surg; 2006; 10(3):139-41. PubMed ID: 17241591
[TBL] [Abstract][Full Text] [Related]
12. Management of "refractory" skin disease in patients with lupus erythematosus.
Callen JP
Best Pract Res Clin Rheumatol; 2005 Oct; 19(5):767-84. PubMed ID: 16150402
[TBL] [Abstract][Full Text] [Related]
13. Chronic cutaneous lupus erythematosus presenting as atypical acneiform and comedonal plaque: case report and literature review.
Vieira ML; Marques ERMC; Leda YLA; Noriega LF; Bet DL; Pereira GAAM
Lupus; 2018 Apr; 27(5):853-857. PubMed ID: 28857716
[TBL] [Abstract][Full Text] [Related]
14. The immunopathology of cutaneous lupus erythematosus.
Kirchhof MG; Dutz JP
Rheum Dis Clin North Am; 2014 Aug; 40(3):455-74, viii. PubMed ID: 25034156
[TBL] [Abstract][Full Text] [Related]
15. Myxovirus Resistance Protein A Is a Useful Additional Histological Marker in Suspected Cutaneous Lupus Erythematosus.
Lambers WM; Diercks GFH; Homan FM; Doornbos-van Meer B; Bootsma H; Westra J; de Leeuw K
Acta Derm Venereol; 2020 Aug; 100(15):adv00234. PubMed ID: 32618348
[TBL] [Abstract][Full Text] [Related]
16. The different faces of cutaneous lupus erythematosus.
Renner R; Sticherling M
G Ital Dermatol Venereol; 2009 Apr; 144(2):135-47. PubMed ID: 19357621
[TBL] [Abstract][Full Text] [Related]
17. [Cutaneous lupus erythematosus, a multidimensional entity].
Méndez-Flores S; Tinoco-Fragoso F; Hernández-Molina G
Rev Med Inst Mex Seguro Soc; 2015; 53(6):764-72. PubMed ID: 26506497
[TBL] [Abstract][Full Text] [Related]
18. [Papular mucinosis. A rare cutaneous manifestation of lupus erythematosus].
Storck R; Schirren CG; Meurer M; Kind P
Hautarzt; 1994 Sep; 45(9):642-6. PubMed ID: 7960774
[TBL] [Abstract][Full Text] [Related]
19. Bullous systemic lupus erythematosus: response to dapsone in two patients.
Sirka CS; Padhi T; Mohanty P; Patel DK; Parida PR; Kar CR
Indian J Dermatol Venereol Leprol; 2005; 71(1):54-6. PubMed ID: 16394370
[No Abstract] [Full Text] [Related]
20. Advances in Cutaneous Lupus Erythematosus and Dermatomyositis: A Report from the 4th International Conference on Cutaneous Lupus Erythematosus-An Ongoing Need for International Consensus and Collaborations.
Concha JSS; Patsatsi A; Marshak-Rothstein A; Liu ML; Sinha AA; Lee LA; Merola JF; Jabbari A; Gudjonsson JE; Chasset F; Jarrett P; Chong B; Arkin L; Fernandez AP; Caproni M; Greenberg SA; Kim HJ; Pearson DR; Femia A; Vleugels RA; Fiorentino D; Fujimoto M; Wenzel J; Werth VP
J Invest Dermatol; 2019 Feb; 139(2):270-276. PubMed ID: 30243657
[No Abstract] [Full Text] [Related]
[Next] [New Search]
